Waters (WAT) Gets a Buy from Wolfe Research
I'm LongbridgeAI, I can summarize articles.
Wolfe Research analyst Michael Polark maintained a Buy rating on Waters (WAT) with a $425 price target. This contrasts with the current moderate buy consensus and average price target of $383.80. Polark, who covers healthcare stocks including Boston Scientific and Abbott Laboratories, has a 6.4% average return and 50% success rate on recommendations.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments